|
- Free Prostate Specific Antigen (PSA)
The free PSA test measures the amount of unbound PSA, whereas routine tests for PSA measure both free and bound PSA or “total” amounts of PSA PSA levels can be elevated in prostate cancer and in a variety of benign conditions including prostatitis, prostate hypertrophy, and advanced age
- PSA Test: What You Need to Know (PDF) | ZERO Prostate Cancer
This one-page summary of the PSA blood test explains one of the key parts of detecting prostate cancer early Download it to print at home or email, or view the document in your web browser
- Prostate-Specific Antigen (PSA) Test Example | Free PDF . . .
Manage your prostate health with Carepatron's PSA Test app Schedule tests, track results, and share securely with healthcare providers Try now
- Free Prostate Cancer Testing Near You | ZERO Prostate Cancer
PSA tests are a crucial tool for detecting prostate cancer ZERO's mapping tool provides a list of locations that offer free or low-cost PSA testing
- PSA Levels By Age Chart: Normal, High Range Scores
PSA Levels by Age Chart (Free to Total Ratio) The main difference between the PSA scores of prostatitis and an enlarged prostate, compared to prostate cancer, is the ratio of free vs bound PSA within your test sample
- PSA, Free and Total | Test Detail | Quest Diagnostics
PSA, Free and Total - In men over 50 years with total PSA between 4 0 and 10 0 ng mL, the percent (%) free PSA gives an estimate of the probability of cancer In these circumstances the measurement of the % free PSA may aid in avoiding unnecessary biopsies
- Prostate Specific Antigen, Free Percentage (Includes Free PSA . . .
The free PSA percentage is an aid in distinguishing prostate cancer from benign prostatic conditions in individuals with a prostate age 50 years and older with a total PSA between 3 and 10ng mL and negative digital rectal examination findings Prostatic biopsy is required for the diagnosis of cancer
- PSA AND FREE-PSA INFORMATION SHEET - SydPath
PSA AND FREE-PSA INFORMATION SHEET PSA TESTING PSA testing can be used as a screening test in asymptomatic men, for investigation of prostatic symptoms or monitoring treatment in men with known prostate cancer
|
|
|